Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Dr Reddys Laboratories (RDY) over the last 13 years, with Q4 2025 value amounting to $2.9 million.

  • Dr Reddys Laboratories' Short-term Investments changed N/A to $2.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.9 million, marking a year-over-year change of. This contributed to the annual value of $506.0 million for FY2025, which is 4327.35% down from last year.
  • As of Q4 2025, Dr Reddys Laboratories' Short-term Investments stood at $2.9 million.
  • In the past 5 years, Dr Reddys Laboratories' Short-term Investments registered a high of $895.4 million during Q1 2024, and its lowest value of $1.5 during Q2 2022.
  • Moreover, its 5-year median value for Short-term Investments was $13.1 million (2021), whereas its average is $148.6 million.
  • As far as peak fluctuations go, Dr Reddys Laboratories' Short-term Investments tumbled by 10000.0% in 2022, and later surged by 148956047867.49% in 2023.
  • Quarter analysis of 5 years shows Dr Reddys Laboratories' Short-term Investments stood at $24.0 million in 2021, then crashed by 90.83% to $2.2 million in 2022, then soared by 301.12% to $8.8 million in 2023, then tumbled by 45.99% to $4.8 million in 2024, then plummeted by 39.1% to $2.9 million in 2025.
  • Its last three reported values are $2.9 million in Q4 2025, $32.5 million for Q3 2025, and $6.4 million during Q1 2025.